Rapid diagnosis of TERT promoter mutation using Terahertz absorption spectroscopy in glioblastoma
Open Access
- 27 May 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-11
Abstract
Glioblastoma (GBM) is a highly aggressive brain tumor with poor outcomes and limited treatment options. The telomerase reverse transcriptase (TERT) promoter mutation, one of the key biomarkers in GBM, is linked to tumor progression and prognosis. This study employed terahertz time-domain spectroscopy (THz-TDS) to analyze frozen GBM tissue sections, extracting six spectral features: absorption coefficient, dielectric loss factor, dielectric constant, extinction coefficient, refractive index, and dielectric loss tangent. LASSO regression was employed for feature selection, and then principal component analysis (PCA) was applied to minimize inter-feature correlations. A Random Forest classifier built on these features successfully predicted TERT mutation status, achieving an area under the receiver operating characteristic curve (AUC) of 0.908 in the validation set. Our findings demonstrate that THz spectroscopy, coupled with machine learning, can identify molecular differences associated with TERT mutations, supporting its potential as a rapid, intraoperative diagnostic tool for personalized GBM treatment. This approach could enhance surgical decision-making and optimize patient outcomes through precise, real-time molecular diagnostics.Keywords
Funding Information
- the Postdoctoral Fellowship Program of CPSF (GZC20231749)
- The National Natural Science Foundation of China (82151310)
- The Beijing Natural Science Foundation (L246018)
- the Beijing Municipal Administration of Hospitals Incubating Program (PX2024019)
This publication has 44 references indexed in Scilit:
- Intraoperative rapid molecular diagnosis aids glioma subtyping and guides precise surgical resectionAnnals of Clinical and Translational Neurology, 2024
- MRI radiomics model for predicting TERT promoter mutation status in glioblastomaBrain and Behavior, 2023
- Prediction of IDH mutation status of glioma based on terahertz spectral dataSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2023
- Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRIJournal of Magnetic Resonance Imaging, 2023
- Biomedical applications of terahertz spectra in clinical and molecular pathology of human gliomaSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2022
- TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastomaActa Neuropathologica, 2021
- Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma’s grade and IDH statusJournal of Neuro-Oncology, 2018
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Rapid Intraoperative Molecular Characterization of GliomaJAMA Oncology, 2015
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q lossActa Neuropathologica, 2013